Isotechnika Announces Agreement From the FDA on a Special Protocol Assessment ... GlobeNewsWire (press release) "With a clear regulatory pathway forward for voclosporin in both the United States and the European Union, we can finalize plans to initiate phase 3 testing of this potential market-leading drug to prevent kidney transplant rejection," stated Dr. |
